COPD: Pathogenesis and Clinical Features
Pneumonia II: Pathophysiology
Cystic Fibrosis: Pathogenesis
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Single Nucleotide Polymorphisms-SNPs
Pneumonia III: Complications and Assessment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 7, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Chandrakumar Shanmugam1, Abdul Rafi Mohammed2, Swarupa Ravuri3
1Department of Pathology, RVM Institute of Medical Sciences & Research Center (KNR University of Health Sciences) Laxmakkapally, Mulugu, Siddipet Dist., Telangana, 502279, India.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes COVID-19, impacting lungs and potentially other organs. This review details COVID-19 pathology and pathogenesis for therapeutic target development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: